Fiche publication


Date publication

juin 2019

Journal

Journal for immunotherapy of cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie , Dr BOIDOT Romain , Pr GHIRINGHELLI François , Dr MIRJOLET Céline , Dr LIMAGNE Emeric , Dr DERANGERE Valentin , Dr FUMET Jean-David , Dr THIBAUDIN Marion


Tous les auteurs :
Grapin M, Richard C, Limagne E, Boidot R, Morgand V, Bertaut A, Derangere V, Laurent PA, Thibaudin M, Fumet JD, Crehange G, Ghiringhelli F, Mirjolet C

Résumé

Radiotherapy (RT) induces an immunogenic antitumor response, but also some immunosuppressive barriers. It remains unclear how different fractionation protocols can modulate the immune microenvironment. Clinical studies are ongoing to evaluate immune checkpoint inhibitors (ICI) in association with RT. However, only few trials aim to optimize the RT fractionation to improve efficacy of these associations. Here we sought to characterize the effect of different fractionation protocols on immune response with a view to associating them with ICI.

Mots clés

Colorectal cancer, Immune response, Immunotherapy, Radiotherapy fractionation

Référence

J Immunother Cancer. 2019 Jun 25;7(1):160